Literature DB >> 20975573

Interleukin 1 β (IL-1B) and IL-1 antagonist receptor (IL-1RN) gene polymorphisms are associated with the genetic susceptibility and steroid dependence in patients with ulcerative colitis.

Jesús K Yamamoto-Furusho1, Jean J Santiago-Hernández, Nonanzit Pérez-Hernández, Silvestre Ramírez-Fuentes, José Manuel Fragoso, Gilberto Vargas-Alarcón.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is an inflammatory bowel disease of unknown etiology. Among cytokines induced in UC, interleukin 1 antagonist (IL-1ra) and interleukin 1 β (IL-1β) seems to have a central role because of its immunoregulatory and proinflammatory activities. GOAL: To determine the association between IL-1RA and IL-1B gene polymorphisms and the clinical features of UC in the Mexican Mestizo population. STUDY: Five polymorphisms in the IL-1 gene cluster members IL-1B (rs16944), IL1F10 (rs3811058), and IL-1RN (rs419598, rs315952, and rs315951) were genotyped by 5' exonuclease TaqMan genotyping assays in a group of 200 Mexican patients with UC and 248 ethnically matched unrelated healthy controls.
RESULTS: We found a significant increased frequencies of IL-1RN6/1 TC (rs315952) and RN6/2 CC (rs315951) and decreased frequency of IL-1B-511 TC (rs16944) genotypes in UC patients as compared with healthy controls. In the subgroup analysis, we found a significant association between the RN6/2 GG (rs315951) and IL-1B-511 CC (rs16944) genotypes and the presence of steroid-dependence in UC patients (pC=00001, OR=15.6 and pC=0.008, OR=4.09, respectively). Patients with UC showed increased frequencies of IL-1RN "CTC" and "TCG" haplotypes when compared with healthy controls (P=0.019, OR=1.43 and P<10(-7), OR=2.63, respectively). Two haplotypes (TTG and CTG) showed decreased frequency in patients when compared with healthy controls (P=9×10(-7), OR=0.11 and P=8×10(-6), OR=0.11, respectively).
CONCLUSIONS: IL-1 RN and IL-1B polymorphisms were associated with the genetic susceptibility to develop UC and might be associated with the presence of steroid-dependence in UC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20975573     DOI: 10.1097/MCG.0b013e3181faec51

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  22 in total

1.  Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

Authors:  Xiaohong Wang; Dan Li; Yong Zhang; Shuang Wu; Fang Tang
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

Review 2.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

3.  Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome?

Authors:  Manuel Muro; Anna Mrowiec
Journal:  Dig Dis Sci       Date:  2015-05       Impact factor: 3.199

4.  Association of the interleukin 15 (IL-15) gene polymorphisms with the risk of developing ulcerative colitis in Mexican individuals.

Authors:  Jesus K Yamamoto-Furusho; Jorge L De-León-Rendón; Edith Alvarez-León; Mario Valdivia-Eziquio; Claudia Obil-Chavarría; Gilberto Vargas-Alarcón
Journal:  Mol Biol Rep       Date:  2014-01-11       Impact factor: 2.316

Review 5.  Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?

Authors:  Mairi H McLean; Markus F Neurath; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

6.  Environmental Factors Modify the Severity of Acute DSS Colitis in Caspase-11-Deficient Mice.

Authors:  Ting-Jia Fan; Sandrine Y Tchaptchet; Diana Arsene; Yoshiyuki Mishima; Bo Liu; R Balfour Sartor; Ian M Carroll; Edward A Miao; Anthony A Fodor; Jonathan J Hansen
Journal:  Inflamm Bowel Dis       Date:  2018-10-12       Impact factor: 5.325

Review 7.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

8.  Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Authors:  Nasser Ebrahimi Daryani; Maryam Sadr; Shirin Moossavi; Sepideh Shahkarami; Samaneh Soltani; Elham Farhadi; Nima Rezaei
Journal:  Dig Dis Sci       Date:  2014-12-03       Impact factor: 3.199

Review 9.  Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.

Authors:  Fiorella Biasi; Gabriella Leonarduzzi; Patricia I Oteiza; Giuseppe Poli
Journal:  Antioxid Redox Signal       Date:  2013-03-01       Impact factor: 8.401

Review 10.  Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.

Authors:  Lili Magyari; Erzsebet Kovesdi; Patricia Sarlos; Andras Javorhazy; Katalin Sumegi; Bela Melegh
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.